Teva Pharmaceutical Indus Stock (NYSE: TEVA) stock price, news, charts, stock research, profile.
|Vol / Avg.4.402M / 8.728M||Mkt Cap11.008B|
|Day Range9.800 - 9.980||52 Wk Range7.085 - 11.445|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|2023-09-08||B of A Securities||Jason Gerberry||Maintains||BuyBuy||Raises||12.00||13.00|
|Ticker||Company||Chg %||Mkt Cap|
|TEVA||Teva Pharmaceutical Indus||-1.5%||11B|
|JNJ||Johnson & Johnson||-0.64%||371.7B|
|MRK||Merck & Co||-0.42%||262.1B|
You can purchase shares of Teva Pharmaceutical Indus (NYSE: TEVA) through any online brokerage.
The latest price target for Teva Pharmaceutical Indus (NYSE: TEVA) was reported by UBS on Monday, November 27, 2023. The analyst firm set a price target for 13.00 expecting TEVA to rise to within 12 months (a possible 32.38% upside). 9 analyst firms have reported ratings in the last year.
The stock price for Teva Pharmaceutical Indus (NYSE: TEVA) is $9.82 last updated December 8, 2023 at 9:00 PM UTC.
A quarterly cash dividend of $0.09 per share of Class A Common Stock. The quarterly cash dividend was payable on December 12, 2017 to stockholders of record on November 28, 2017.
Teva Pharmaceutical Indus’s Q4 earnings are confirmed for Wednesday, February 7, 2024.
There is no upcoming split for Teva Pharmaceutical Indus.
Teva Pharmaceutical Indus is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.